MRKR vs ZTS · rev $751.7K vs P/E 25, rev $2.47B
Marker Therapeutics Inc (MRKR) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
MRKR currently screens at market cap $25.3M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the MRKR and ZTS stock pages for the full models.
Not investment advice.